What is Coapt?
Coapt, LLC operates at the intersection of biomechanics and artificial intelligence, specializing in advanced myoelectric pattern recognition for upper limb prosthetics. The company's flagship Complete Control system leverages sophisticated machine-learning algorithms to decode complex muscle signal patterns, facilitating a more fluid and intuitive user experience. By providing a universal interface compatible with a broad spectrum of existing prosthetic components, Coapt addresses critical gaps in the current market for limb replacement solutions. Their Gen2 system represents a significant leap forward in prosthetic development, effectively bridging the gap between human intent and mechanical execution for individuals with upper limb amputations or congenital limb differences. Through this focus on high-fidelity signal processing, the company has established itself as a pivotal player in the assistive technology landscape, prioritizing user autonomy and quality of life improvements.
How much funding has Coapt raised?
Coapt has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Coapt
PPP
Public-Private Partnership
What's next for Coapt?
With the recent influx of capital, Coapt is well-positioned to accelerate its research and development initiatives, focusing on the next generation of neural-interface integration. The company is expected to scale its commercial operations, expanding the reach of its Gen2 system to a broader global demographic. Strategic priorities likely include deepening clinical partnerships to validate long-term patient outcomes and refining the machine-learning models to further reduce latency in prosthetic response times. As the firm transitions through this late-stage growth phase, the focus will remain on maintaining its technological moat while navigating the regulatory complexities inherent in the medical device industry. By leveraging its current financial backing, Coapt aims to solidify its dominance in the prosthetic control market, setting a new benchmark for intuitive, human-centric assistive technology.
See full Coapt company page
